Table 1.
Baseline patient characteristics. Abbrev. EBV = Ebstein–Barr Virus, N/A: Not Available, TNM = Tumor Node Metastasis, WHO = World Health Organization.
Characteristic | N | % | |
---|---|---|---|
Age | <65 years | 35 | 76.1 |
≥65 years | 11 | 23.9 | |
Sex | Male | 36 | 78.3 |
Female | 10 | 21.7 | |
History of tobacco use | Active smoker | 14 | 30.4 |
Former smoker | 11 | 23.9 | |
Nonsmoker | 21 | 45.7 | |
History of alcohol consumption | No | 41 | 89.1 |
Moderate/Heavy | 5 | 10.9 | |
Charlson comorbidity index | ≤2 | 16 | 34.8 |
>2 | 22 | 47.8 | |
N/A | 8 | 17.4 | |
Site of metastasis | Lung | 10 | 21.7 |
Bone | 16 | 34.8 | |
Liver | 11 | 23.9 | |
Other | 6 | 13 | |
None | 17 | 36.9 | |
Stage TNM | II–III | 18 | 39.1 |
IV | 24 | 52.2 | |
N/A | 4 | 8.7 | |
Histology (WHO classification) | Nonkeratinizing squamous cell carcinoma | 40 | 86.9 |
Keratinizing squamous cell carcinoma | 3 | 6.5 | |
Basaloid | 1 | 2.2 | |
Pretreatment plasma EBV DNA | N/A | 2 | 4.4 |
Positive | 18 | 39.1 | |
Negative | 13 | 28.3 | |
Unavailable | 15 | 32.6 |